| Title : Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of beta-cell function in patients with type 2 diabetes - Yoon_2011_Int.J.Clin.Pract_65_154 |
| Author(s) : Yoon KH , Shockey GR , Teng R , Golm GT , Thakkar PR , Meehan AG , Williams-Herman DE , Kaufman KD , Amatruda JM , Steinberg H |
| Ref : Int J Clin Pract , 65 :154 , 2011 |
| Abstract : Yoon_2011_Int.J.Clin.Pract_65_154 |
| ESTHER : Yoon_2011_Int.J.Clin.Pract_65_154 |
| PubMedSearch : Yoon_2011_Int.J.Clin.Pract_65_154 |
| PubMedID: 21235696 |
Yoon KH, Shockey GR, Teng R, Golm GT, Thakkar PR, Meehan AG, Williams-Herman DE, Kaufman KD, Amatruda JM, Steinberg H (2011)
Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of beta-cell function in patients with type 2 diabetes
Int J Clin Pract
65 :154
Yoon KH, Shockey GR, Teng R, Golm GT, Thakkar PR, Meehan AG, Williams-Herman DE, Kaufman KD, Amatruda JM, Steinberg H (2011)
Int J Clin Pract
65 :154